Compare CTAS & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTAS | BSX |
|---|---|---|
| Founded | 1968 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.1B | 137.8B |
| IPO Year | 1994 | 2010 |
| Metric | CTAS | BSX |
|---|---|---|
| Price | $193.20 | $68.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 20 |
| Target Price | ★ $222.75 | $108.75 |
| AVG Volume (30 Days) | 1.6M | ★ 11.6M |
| Earning Date | 03-19-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 2.41 | 1.94 |
| Revenue | $6,892,303,000.00 | ★ $9,076,000,000.00 |
| Revenue This Year | $10.48 | $12.04 |
| Revenue Next Year | $7.43 | $10.48 |
| P/E Ratio | $82.24 | ★ $35.87 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $180.39 | $68.25 |
| 52 Week High | $229.24 | $109.50 |
| Indicator | CTAS | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 28.12 |
| Support Level | $192.44 | N/A |
| Resistance Level | $197.01 | $76.77 |
| Average True Range (ATR) | 4.58 | 1.86 |
| MACD | -0.73 | 0.04 |
| Stochastic Oscillator | 0.14 | 11.95 |
Cintas has roots tracing back to 1929, during which the Farmer family cleaned and re-sold dirty rags to manufacturing plants in Ohio. The firm has grown its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. In the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid, fire, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.